Michael Oreilly
Obstetrics & Gynecology · Shelton, CTNPI 1891723995
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 25.6% of the total. Reporting peaked in 2022 at $1,381 and has fallen 95.7% since, to $59 in 2023.
Across 127 payments — averaging $22.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$716
- Exeltis, USA Inc.$528
- Agile Therapeutics, Inc.$175
- Therapeuticsmd, Inc.$168
- Bayer$159
- Avion Pharmaceuticals$159
- plus $890 from 17 others
What the payments were for
- Food & beverage$2,75799%
- Education$371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 36 | $716 |
| Exeltis, USA Inc. | 11 | $528 |
| Agile Therapeutics, Inc. | 9 | $175 |
| Therapeuticsmd, Inc. | 10 | $168 |
| Bayer | 9 | $159 |
| Avion Pharmaceuticals | 5 | $159 |
| Mayne Pharma Commercial LLC | 5 | $114 |
| Evofem Biosciences, Inc. | 5 | $99 |
| Lupin Inc. | 6 | $87 |
| Organon | 4 | $66 |
| Pacira Pharmaceuticals Incorporated | 3 | $66 |
| Medtronic | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Merck | 4 | $54 |
| Pfizer | 3 | $51 |
| Duchesnay USA Incorporated | 2 | $38 |
| Myovant Sciences Inc. | 2 | $38 |
| AMAG Pharmaceuticals, Inc. | 2 | $37 |
| Vertical Pharmaceuticals, LLC | 2 | $33 |
| Astellas Pharma US Inc | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Urovant Sciences Inc | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
How this compares
$2,794 in reported general payments places this provider in the 85th percentile of 605 obstetrics & gynecology providers in Connecticut.
Other obstetrics & gynecology in Shelton
- Rachel BernsteinShelton$4K
- Scott Vander VennetShelton$4K
- Mary MinkinNew Haven$285K
- Alessandro SantinNew Haven$98K
- Frederick RauHartford$89K
- Peter AuerbachGroton$41K
- Shieva GhofranyStamford$33K
- Mark LeondiresNorwalk$31K
- Alan FineHartford$30K
- Sean FlahertyHamden$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.